The IPOX® Week #718

 
 

IPOX® Indexes rise as Nasdaq 100 Momentum decelerates.
IPOX® Nordic, IPOX® China, GINDEX® record big weekly gains, outperform.
P/E-backed BTSG slumps in NY-trading debut. Biotech IPOs shine.
Read about the IPOs set to commence trading this week below.

IPOX® PERFORMANCE REVIEW: The IPOX® Indexes finished the week broadly higher, as U.S. yields drifted up anew, earnings releases were negative for select stocks, and equity risk remained stable (VIX US: -0.30%). In the U.S. and ahead of earnings for some of its key members, e.g., the IPOX® 100 U.S. (ETF: FPX), benchmark for the performance of the typically largest and best performing U.S. domiciled IPOs, added +0.64% to -1.55% YTD, in line with the Nasdaq 100 (NDX), which saw its big Momentum decelerate towards the weekend. Except for the IPOX® MENA (IPEV), strength extended to markets capturing non-U.S. domiciled stocks with the IPOX® China (CNI) and IPOX® Nordic (IPND) leading the way. Indeed, and underlying the impact of the current dislocation across China-domiciled equities, the IPOX® China (CNI) extended its YTD relative advance vs. benchmark Hang Seng Tech (HSTECH) to a massive +849 bps. We also note the good week for acquirers of IPOX® members captured in GINDEX® U.S. (GNDX) and GINDEX® International (GNDXI) with earnings generally positively impacting the performance of the highly liquid portfolios, adding +1.41% and +1.31% last week, respectively. 

 
 

IPOX® STOCKS IN FOCUS:  In the U.S., 63/100 companies in the IPOX® 100 U.S. (ETF: FPX) rose last week, with the average (median) portfolio holding adding +0.91% (+0.63%), outperforming the applied market-cap weighted index. Amid more biotech buy-out and IPO frenzy, top of the list ranked development stage biotech Arcellx (ACLX US: +13.66%), followed by online education stock Coursera (COUR US: +13.10%) and AI-solutions provider AppLovin (APP US: +7.68%). Expectations about an additional guest fee perceived to propel future revenue also pushed heavyweight vacation rental marketplace Airbnb (ABNB US: +6.92%) to a strong week. Coconut water maker The Vita Coco Co. (COCO US: -10.15%) as well as factory automation equipment maker Symbotic (SYM US: -7.03%) ranked as the worst performing portfolio holdings. Across non-U.S. domiciled stocks, the story of the week belonged to German-biotech Morphosys (MOR GY: +22.00%), a firm tracked in the IPOX® 100 Europe (ETF: FPXE).  The stock soared amid sector enthusiasm, alongside other European-domiciled IPOX®-held biotechs including Dutch-based Pharvaris (PHVS US: +9.71%), Swiss-based Moonlake Therapeutics (MLTX US: +6.82%) and Swedens Bonesupport (BONEX SS: +5.74%). Strong gains across Nordic small-caps including sports media marketing firm Better Collective (BETCO SS: +10.55%), application software maker Link Mobility (LINK NO: +8.47%) and BW Energy (BWE NO: +5.86%) also drove the IPOX® Nordic (IPND) to a fresh multi-year high. Big advanced in stocks extended to select IPOX® exposure across the Middle East and Japan, notably Saudi hospital operator Dr. Sulaiman Al-Habib (SULAIMAN AB: +5.65%) and Japan’s leading fintech M&A Research (9552 JP: +8.55%).  U.S. sanctions concerns pressured Chinese biotech Wuxi CDX Cayman (2268 HK: -17.92%) which ranked at the bottom of the IPOX® Indexes last week. 

 

IPO MARKET REVIEW: Four significant IPOs commenced trading last week, with the average (median) company adding +95.02% (+47.74%) based on the difference between the final offering price and first close. Top of the list ranked Korean shipbuilding components maker small-cap Hyundai Hyms (460930 KS: +300%), while biotech IPO M&A fever clearly pushed sentiment for U.S.-traded CG oncology (CGON US: +84.37%) and ArriVent (AVBP US: +11.11%). After cutting size and range, the largest deal of the week, however, the IPO of U.S. health services provider KKR-backed capital structure deal Bright Spring Health Services (BTSG US: -15.38%) flopped. 

 

NOTABLE GLOBAL IPO DEAL FLOW WEEK 01/29/24: With more companies filing, notable ECM activity is set to involve the following companies: U.S. software maker micro-cap Docola Inc. (DOCO US), micro-cap H.K. based Financial PR Services Provider Intelligent Group (INTJ US), small-cap U.S. biotech FibroBiologics (FBLG US) and Saudi Pharma maker Avalon Pharma. The largest and most significant deals belong to sportswear maker Helsinki-based Amer Sports (AS US) and Sodexo Spinoff Pluxee (PLX FP).  

 

IPOX® SPAC INDEX (SPAC): The Index of 50 constituents trading at both the pre- and post-consummation added +0.94% to -2.61% YTD. IPOX® SPAC Leaders last week was Mexican household products distributor Betterware de Mexico (MWMX US: +9.20%). Warehouse supply chain robotic company Symbotic (SYM US: -7.03%) fell as a series of insiders reports sales. Other SPAC news from last week include: 1) 1 SPAC Announced Merger Agreement include CSLM Acquisition (CSLM US: +0.18%) with Nepal-based AI software company Fusemachine. 2) 2 SPACs Approved/Completed Business Combinations include Deep Medicine Acquisition (DMAQ US: -3.86%) approved merger with golf simulator company TruGolf (TRUG: TBA). 3) 2 SPACs announced to liquidate. 4) No new SPAC launched last week in the U.S.  

 

Follow our IPO Calendar and social media channels (e.g. Linkedin) for the latest ECM IPO News.

 
 
Previous
Previous

The IPOX® Update 1/29/24

Next
Next

The IPOX® Update 1/24/24